IS1663B - Ný 8-súbstitúeruð-2-amínótetralín - Google Patents

Ný 8-súbstitúeruð-2-amínótetralín

Info

Publication number: IS1663B
Authority: IS; Iceland
Prior art keywords: substituted; hydrogen; compounds; fused; alkyl
Prior art date: 1989-05-26

Application number

IS3580A

Other languages

English (en)

Other versions

IS3580A7 (is

Inventor

Andén Nils-Erik

Christina Elisabet Backlund Höök Berit

Original Assignee

Aktiebolaget Astra

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-05-26

Filing date

1990-05-23

Publication date

1997-07-04

1990-05-23 Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra

1990-11-27 Publication of IS3580A7 publication Critical patent/IS3580A7/is

1997-07-04 Publication of IS1663B publication Critical patent/IS1663B/is

Links

-1 8-substituted-2-aminotetraline Chemical class 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 4
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
125000003118 aryl group Chemical group 0.000 abstract 2
125000005842 heteroatom Chemical group 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
229910052760 oxygen Inorganic materials 0.000 abstract 2
229910052717 sulfur Inorganic materials 0.000 abstract 2
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/46—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C229/50—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups and carboxyl groups bound to carbon atoms being part of the same condensed ring system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Nutrition Science (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Indole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Thiazole And Isothizaole Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Furan Compounds (AREA)
Hydrogenated Pyridines (AREA)
Saccharide Compounds (AREA)

IS3580A 1989-05-26 1990-05-23 Ný 8-súbstitúeruð-2-amínótetralín IS1663B (is)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE8901889A SE8901889D0 (sv)	1989-05-26	1989-05-26	Novel 8-substituted-2-aminotetralines

Publications (2)

Publication Number	Publication Date
IS3580A7 IS3580A7 (is)	1990-11-27
IS1663B true IS1663B (is)	1997-07-04

Family

ID=20376074

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS3580A IS1663B (is)	1989-05-26	1990-05-23	Ný 8-súbstitúeruð-2-amínótetralín

Country Status (41)

Country	Link
US (1)	US5635537A (is)
EP (1)	EP0399982B1 (is)
JP (1)	JP2818692B2 (is)
KR (1)	KR100193981B1 (is)
CN (1)	CN1023399C (is)
AT (1)	ATE129696T1 (is)
AU (1)	AU644081B2 (is)
CA (1)	CA2032498C (is)
CY (1)	CY1989A (is)
CZ (1)	CZ286038B6 (is)
DD (1)	DD298909A5 (is)
DE (1)	DE69023274T2 (is)
DK (1)	DK0399982T3 (is)
DZ (1)	DZ1417A1 (is)
ES (1)	ES2078962T3 (is)
FI (1)	FI114151B (is)
GR (1)	GR3018566T3 (is)
HK (1)	HK55697A (is)
HR (1)	HRP920622B1 (is)
HU (2)	HUT58685A (is)
IE (1)	IE75057B1 (is)
IL (1)	IL94428A (is)
IS (1)	IS1663B (is)
JO (1)	JO1617B1 (is)
LT (1)	LT3966B (is)
LV (2)	LV10243B (is)
MX (1)	MX20842A (is)
NO (1)	NO176603C (is)
NZ (1)	NZ233724A (is)
PH (1)	PH31110A (is)
PL (2)	PL165166B1 (is)
PT (1)	PT94163B (is)
RU (1)	RU2093507C1 (is)
SA (1)	SA90100274B1 (is)
SE (1)	SE8901889D0 (is)
SI (1)	SI9011006B (is)
SK (1)	SK256090A3 (is)
UA (1)	UA40562C2 (is)
WO (1)	WO1990014330A1 (is)
YU (1)	YU48830B (is)
ZA (1)	ZA903801B (is)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2785879B2 (ja)	1989-05-31	1998-08-13	ジ・アップジョン・カンパニー	治療学的に有用な２―アミノテトラリン誘導体
EP0471515B1 (en) *	1990-08-15	1997-03-05	Eli Lilly And Company	Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes and 3-aminothiochromanes
US5643784A (en) *	1990-12-04	1997-07-01	H, Lundbeck A/S	Indan derivatives
IL114760A (en) *	1991-02-08	1997-11-20	Lilly Co Eli	Ring-substituted-2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes intermediates thereto
US5643934A (en) *	1991-03-28	1997-07-01	Eli Lilly And Company	6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz [CD]indoles
US5244911A (en) *	1991-03-28	1993-09-14	Eli Lilly And Company	6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz(cd)indoles and pharmaceutical use thereof
US5347013A (en) *	1991-03-28	1994-09-13	Eli Lilly And Company	6-heterocyclic-4-amino-1,2,2a,3,4,5-hexahydrobenz[cd]indoles
US5244912A (en) *	1991-03-28	1993-09-14	Eli Lilly And Company	6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof
NZ243065A (en)	1991-06-13	1995-07-26	Lundbeck & Co As H	Piperidine derivatives and pharmaceutical compositions
SE9103745D0 (sv) *	1991-12-18	1991-12-18	Wikstroem Haakan	Aryl-triflates and related compounds
DK78692D0 (da) *	1992-06-12	1992-06-12	Lundbeck & Co As H	Dimere piperidin- og piperazinderivater
SE9301732D0 (sv) *	1993-05-18	1993-05-18	Haakan Wilhelm Wikstroem	New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins
AU1106195A (en) *	1994-11-09	1996-06-06	Novo Nordisk A/S	Heterocyclic compounds, their preparation and use
GB9509156D0 (en) *	1995-05-05	1995-06-28	Sandoz Ltd	Organic compounds
CN101119965B (zh) *	2004-12-21	2012-09-26	弗·哈夫曼-拉罗切有限公司	萘满和茚满衍生物及其用途
ATE409179T1 (de) *	2004-12-21	2008-10-15	Hoffmann La Roche	Tetralin- und indanderivate und deren anwendungen als 5-ht-antagonisten
US8053603B2 (en)	2006-01-06	2011-11-08	Sunovion Pharmaceuticals Inc.	Tetralone-based monoamine reuptake inhibitors
EP4308603A1 (en)	2021-03-17	2024-01-24	Receptos Llc	Methods of treating atopic dermatitis with anti il-13 antibodies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2752659A1 (de) *	1976-12-07	1978-06-08	Sandoz Ag	Neue tetralinderivate, ihre herstellung und verwendung
US4247907A (en) *	1978-11-27	1981-01-27	International Business Machines Corporation	Method and apparatus for typing characters and optically readable binary representations thereof on same page
SE8004002L (sv) *	1980-05-29	1981-11-30	Arvidsson Folke Lars Erik	Terapeutiskt anvendbara tetralinderivat
IL65501A (en) *	1981-05-08	1986-04-29	Astra Laekemedel Ab	1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
DE3479314D1 (en) *	1984-05-22	1989-09-14	Nelson Res & Dev	Substituted 2-aminotetralins and processes for synthesis
DE3660959D1 (de) *	1985-06-26	1988-11-24	Smithkline Beckman Corp	Benz-trisubstituted 2-aminotetralins
IL79323A (en) *	1985-07-10	1990-03-19	Sanofi Sa	Phenylethanolaminotetralines,their preparation and pharmaceutical compositions containing them
DE3718317A1 (de) *	1986-12-10	1988-06-16	Bayer Ag	Substituierte basische 2-aminotetraline
DE3719924A1 (de) *	1986-12-22	1988-06-30	Bayer Ag	8-substituierte 2-aminotetraline
DK0452390T3 (da) *	1989-01-09	1995-04-03	Upjohn Co	Halogensubstituerede aminotetraliner
JP2785879B2 (ja) *	1989-05-31	1998-08-13	ジ・アップジョン・カンパニー	治療学的に有用な２―アミノテトラリン誘導体

1989
- 1989-05-26 SE SE8901889A patent/SE8901889D0/xx unknown
1990
- 1990-05-17 IL IL9442890A patent/IL94428A/en not_active IP Right Cessation
- 1990-05-17 ZA ZA903801A patent/ZA903801B/xx unknown
- 1990-05-18 NZ NZ233724A patent/NZ233724A/xx unknown
- 1990-05-22 IE IE183390A patent/IE75057B1/en not_active IP Right Cessation
- 1990-05-23 KR KR1019910700092A patent/KR100193981B1/ko not_active Expired - Fee Related
- 1990-05-23 DE DE69023274T patent/DE69023274T2/de not_active Expired - Lifetime
- 1990-05-23 JP JP2508698A patent/JP2818692B2/ja not_active Expired - Lifetime
- 1990-05-23 HU HU904810A patent/HUT58685A/hu unknown
- 1990-05-23 AT AT90850209T patent/ATE129696T1/de not_active IP Right Cessation
- 1990-05-23 ES ES90850209T patent/ES2078962T3/es not_active Expired - Lifetime
- 1990-05-23 EP EP90850209A patent/EP0399982B1/en not_active Expired - Lifetime
- 1990-05-23 DZ DZ900088A patent/DZ1417A1/fr active
- 1990-05-23 MX MX2084290A patent/MX20842A/es unknown
- 1990-05-23 UA UA4894777A patent/UA40562C2/uk unknown
- 1990-05-23 RU SU904894777A patent/RU2093507C1/ru active
- 1990-05-23 DK DK90850209.9T patent/DK0399982T3/da active
- 1990-05-23 SI SI9011006A patent/SI9011006B/sl unknown
- 1990-05-23 CA CA002032498A patent/CA2032498C/en not_active Expired - Lifetime
- 1990-05-23 IS IS3580A patent/IS1663B/is unknown
- 1990-05-23 YU YU100690A patent/YU48830B/sh unknown
- 1990-05-23 WO PCT/SE1990/000351 patent/WO1990014330A1/en not_active Ceased
- 1990-05-23 AU AU58185/90A patent/AU644081B2/en not_active Expired
- 1990-05-24 PL PL90285330A patent/PL165166B1/pl unknown
- 1990-05-24 PL PL90300984A patent/PL164245B1/pl unknown
- 1990-05-25 PT PT94163A patent/PT94163B/pt not_active IP Right Cessation
- 1990-05-25 CZ CS902560A patent/CZ286038B6/cs not_active IP Right Cessation
- 1990-05-25 SK SK2560-90A patent/SK256090A3/sk not_active IP Right Cessation
- 1990-05-25 DD DD90340992A patent/DD298909A5/de unknown
- 1990-05-25 PH PH40567A patent/PH31110A/en unknown
- 1990-05-26 JO JO19901617A patent/JO1617B1/en active
- 1990-05-26 CN CN90103956A patent/CN1023399C/zh not_active Expired - Lifetime
- 1990-06-09 SA SA90100274A patent/SA90100274B1/ar unknown
1991
- 1991-01-25 FI FI910381A patent/FI114151B/fi active
- 1991-01-25 NO NO910310A patent/NO176603C/no not_active IP Right Cessation
1992
- 1992-09-30 HR HRP-1006/90A patent/HRP920622B1/xx not_active IP Right Cessation
1993
- 1993-03-18 US US08/033,013 patent/US5635537A/en not_active Expired - Lifetime
- 1993-06-30 LV LVP-93-869A patent/LV10243B/xx unknown
- 1993-12-30 LT LTIP1723A patent/LT3966B/lt not_active IP Right Cessation
1995
- 1995-06-30 HU HU95P/P00719P patent/HU211880A9/hu unknown
- 1995-12-29 GR GR950403703T patent/GR3018566T3/el unknown
1996
- 1996-11-01 LV LVP-96-420A patent/LV11736B/en unknown
1997
- 1997-05-01 HK HK55697A patent/HK55697A/en not_active IP Right Cessation
- 1997-09-05 CY CY198997A patent/CY1989A/xx unknown

Also Published As

Publication number	Publication date
NO910310D0 (no)	1991-01-25
NO176603B (no)	1995-01-23
PL165166B1 (pl)	1994-11-30
SA90100274B1 (ar)	2005-06-01
LV11736A (lv)	1997-04-20
ATE129696T1 (de)	1995-11-15
YU100690A (en)	1992-05-28
ZA903801B (en)	1991-01-30
FI910381A0 (fi)	1991-01-25
HK55697A (en)	1997-05-09
SI9011006B (sl)	1998-12-31
PL164245B1 (pl)	1994-07-29
HRP920622B1 (en)	2000-04-30
EP0399982B1 (en)	1995-11-02
US5635537A (en)	1997-06-03
GR3018566T3 (en)	1996-03-31
DE69023274T2 (de)	1996-04-11
LV11736B (en)	1997-10-20
HU904810D0 (en)	1991-06-28
FI114151B (fi)	2004-08-31
KR920701121A (ko)	1992-08-11
CA2032498A1 (en)	1990-11-27
SE8901889D0 (sv)	1989-05-26
CN1023399C (zh)	1994-01-05
PL285330A1 (en)	1991-11-04
SK280731B6 (sk)	2000-07-11
NO176603C (no)	1995-05-03
LTIP1723A (en)	1995-08-25
PH31110A (en)	1998-02-23
SK256090A3 (en)	2000-07-11
NO910310L (no)	1991-01-25
ES2078962T3 (es)	1996-01-01
SI9011006A (en)	1997-12-31
JP2818692B2 (ja)	1998-10-30
DK0399982T3 (da)	1996-03-04
IE75057B1 (en)	1997-08-27
DE69023274D1 (de)	1995-12-07
HRP920622A2 (en)	1998-06-30
JPH04500362A (ja)	1992-01-23
CZ286038B6 (cs)	1999-12-15
NZ233724A (en)	1993-01-27
KR100193981B1 (ko)	1999-06-15
WO1990014330A1 (en)	1990-11-29
DZ1417A1 (fr)	2004-09-13
RU2093507C1 (ru)	1997-10-20
LV10243B (en)	1995-04-20
CA2032498C (en)	2002-03-26
AU5818590A (en)	1990-12-18
AU644081B2 (en)	1993-12-02
IS3580A7 (is)	1990-11-27
PT94163B (pt)	1996-12-31
IL94428A0 (en)	1991-03-10
YU48830B (sh)	2002-03-18
HU211880A9 (en)	1995-12-28
IE901833L (en)	1990-11-26
PT94163A (pt)	1991-01-08
LT3966B (en)	1996-05-27
HUT58685A (en)	1992-03-30
CY1989A (en)	1997-09-05
CN1047494A (zh)	1990-12-05
MX20842A (es)	1993-11-01
JO1617B1 (en)	1991-11-27
CZ256090A3 (cs)	1999-10-13
DD298909A5 (de)	1992-03-19
IL94428A (en)	1995-12-31
EP0399982A1 (en)	1990-11-28
LV10243A (lv)	1994-10-20
UA40562C2 (uk)	2001-08-15

Publication	Publication Date	Title
ES2078962T3 (es)	1996-01-01	Nuevas 8-sustituidas-2-amino-tetralinas.
SE8605504D0 (sv)	1986-12-19	Novel chroman derivatives
DK143483D0 (da)	1983-03-29	Fremgangsmade til fremstilling af enantiomerer af substituerede fenylazacykloalkaner
DK162188A (da)	1988-09-27	Fremgangsmaade til fremstilling af pentandionderivater
DK601883D0 (da)	1983-12-27	Phenyl-propanolderivater
SE8802162D0 (sv)	1988-06-09	Nya aminoacylater av glycerolacetal